Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ursodiol in Huntington's disease

Trial Profile

Ursodiol in Huntington's disease

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 04 Feb 2009

At a glance

  • Drugs Ursodeoxycholic acid (Primary)
  • Indications Huntington's disease
  • Focus Adverse reactions; Pharmacokinetics
  • Acronyms UDCA-HD
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 04 Feb 2009 Planned end date changed from Oct 2008 to Jun 2009 as reported by ClinicalTrials.gov.
    • 04 Feb 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top